Key terms

About RARE

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RARE news

Today 11:26am ET Bank of America Securities Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE) by TipRanks Today 8:21am ET Wedbush Reaffirms Their Hold Rating on Ultragenyx Pharmaceutical (RARE) by TipRanks Today 7:38am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Cigna (CI) and Genmab (GMAB) by TipRanks Today 7:30am ET Truist Financial Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE) by TipRanks Today 6:47am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Amgen (AMGN) and Zimmer Biomet Holdings (ZBH) by TipRanks Apr 30 8:36am ET Ultragenyx announces completion of enrollment in Phase 3 studies of setrusumab by TipRanks Apr 30 6:21am ET Ultragenyx Pharmaceutical: Strong Buy Rating on Growth Prospects and Pipeline Potential by TipRanks Apr 24 7:26am ET Ultragenyx price target raised to $61 from $59 at TD Cowen by TipRanks Apr 23 8:40am ET Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Ultragenyx Pharmaceutical (RARE) by TipRanks Apr 22 10:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Apr 22 8:29am ET Piper Sandler Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE) by TipRanks Apr 22 4:50am ET Ultragenyx initiated with an Outperform at RBC Capital by TipRanks Apr 18 6:10am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY) by TipRanks Apr 18 12:26am ET Buy Rating on Ultragenyx Pharmaceutical Bolstered by GTX-102’s Promise and Positive Valuation Outlook by TipRanks Apr 17 7:45am ET 3 Best Stocks to Buy Now, 4/17/2024, According to Top Analysts by TipRanks Apr 16 8:11am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Intra-Cellular Therapies (ITCI) by TipRanks Apr 16 8:00am ET Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Ultragenyx Pharmaceutical (RARE) by TipRanks Apr 15 8:40pm ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and 23andMe Holding (ME) by TipRanks Apr 15 7:08am ET Ultragenyx announces results from interim Phase 1/2 data of GTX-102 by TipRanks Apr 15 6:10am ET Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Ultragenyx Pharmaceutical (RARE) by TipRanks Apr 09 5:50am ET Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Veeva Systems (VEEV) and Ultragenyx Pharmaceutical (RARE) by TipRanks Apr 08 3:40am ET Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Ultragenyx Pharmaceutical (RARE) and Opthea Limited Sponsored ADR (OPT) by TipRanks Apr 04 10:25am ET Ultragenyx participates in a conference call hosted by Cantor Fitzgerald by TipRanks Apr 04 7:37am ET Ultragenyx participates in a conference call hosted by Cantor Fitzgerald by TipRanks Mar 19 7:10am ET Analysts Offer Insights on Healthcare Companies: eFFECTOR Therapeutics (EFTR), Apellis Pharmaceuticals (APLS) and Ultragenyx Pharmaceutical (RARE) by TipRanks Mar 18 7:15am ET JPMorgan ups Ultragenyx target, opens ‘Positive Catalyst Watch’ into data by TipRanks Mar 14 6:50am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Cannabist Company Holdings (OtherCBSTF) by TipRanks Feb 27 8:40am ET Analysts Are Bullish on These Healthcare Stocks: Ultragenyx Pharmaceutical (RARE), Rocket Pharmaceuticals (RCKT) by TipRanks Feb 21 8:06am ET Ultragenyx Pharmaceutical: A Strong Buy on Robust Crysvita Sales and Promising Pipeline Prospects by TipRanks Feb 21 7:37am ET Ultragenyx price target raised to $111 from $110 at TD Cowen by TipRanks Feb 18 11:50pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks
Mar 15 12:43pm ET Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical, Inc. to Contact Law Firm by Newsfile

RARE Financials

1-year income & revenue

Key terms

RARE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RARE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Markets jump higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again
The Marriner S. Eccles Federal Reserve building in Washington, DC, on Thursday, Dec. 28, 2023.
Valerie Plesch/Bloomberg/Getty Images
The Fed announced a big change today. And no, we’re not talking about interest rates